Page last updated: 2024-12-07

g 25671

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

G 25671: metabolite of sulfinpyrazone; inhibits human platelet cyclo-oxygenase activity [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID77327
CHEBI ID143292
SCHEMBL ID11192960
MeSH IDM0124884

Synonyms (32)

Synonym
unii-bh57g6g6bn
3736-92-3
1,2-diphenyl-3,5-dioxo-4-(2'-phenyl-thio-aethyl)-pyrazolidin
g-25671
1,2-diphenyl-4-(2-(phenylthio)ethyl)-3,5-pyrazolidinedione
bh57g6g6bn ,
brn 0344102
1,2-diphenyl-4-phenylthioethyl-3,5-pyrazolidinedione
1,2-diphenyl-3,5-dioxo-4-(2'-phenyl-thio-aethyl)-pyrazolidin [german]
1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione
3,5-pyrazolidinedione, 1,2-diphenyl-4-(2-(phenylthio)ethyl)-
gp 25671
g 25671
einecs 223-109-7
4-(phenylthioethyl)-1,2-diphenyl-3,5-pyrazolidine-dione
1,2-diphenyl-4-(2-phenylsulfanylethyl)pyrazolidine-3,5-dione
1,2-diphenyl-4-(2-(phenylthio)ethyl)pyrazolidine-3,5-dione
1,2-diphenyl-4-[2-(phenylthio)ethyl]-3,5-pyrazolidinedione
PLGXGMUJUXKCDD-UHFFFAOYSA-N
4-(phenylthioethyl)-1,2-diphenyl 3,5-pyrazolidinedione
SCHEMBL11192960
sulfinpyrazone sulfide
DTXSID90190808
3,5-pyrazolidinedione, 1,2-diphenyl-4-[2-(phenylthio)ethyl]-
CHEBI:143292
1,2-diphenyl-4-[2-(phenylsulfanyl)-ethyl]pyrazolidine-3,5-dione
1,2-diphenyl-4-[2-(phenylsulfanyl)-ethyl]pyrazolidine-3,5-dione; sulfinpyrazone impurity b (ep); 1,2-diphenyl-4-(2-phenylthioethyl)pyrazolidine-3,5-dione; sulfinpyrazone impurity b
sulfinpyrazone impurity b [ep impurity]
4-(2-(phenylthio)ethyl)-1,2-diphenyl-3,5-pyrazolidinedione
1,2-diphenyl-4-(2-(phenylsulfanyl)ethyl)pyrazolidine-3,5-dione
1,2-diphenyl-4-(2-phenylthioethyl)-3,5-pyrazolidinedione
sulfinpyrazone impurity b
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aryl sulfideAny organic sulfide in which the sulfur is attached to at least one aromatic group.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (85.71)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.25

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.25 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.45 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.25)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]